• 한국식품영양과학회지
• /
• 제30권5호
• /
• pp.782-786
• /
• 2001

본 연구는 수산가공용 풍미소재 검색 및 인스탄트식품용 조미소재의 개발, 연안에서 생산되는 저활용 수산자원의 유효이용이라는 관점에서 소형 창오징어를 원료로 열수추출엑스분, 자가소화엑스분 및 2단 효소분해엑스분의 조제하여 이들의 정미특성과 기능성을 분석.비교하였다. 소형 창오징어 열수추출 및 자가소화엑스분, 2단 효소분해엑스분의 유리아미노산 총량은 각각 2,792.5 mg%, 8,393.8 mg% 및 9,186.1 mg%이었고, 2단 효소분해엑스분에는 Asn, Gln, val, Ile 및 Lys이 다량 함유되어 있었다. ATP관련물질 중 AMP 함량은 34.6~51.6 mg% 함유되어 있었고, 추출에 따른 함량 차이는 크지 않았다. 무기이온 성분으로서 Na, Cl 및 PO$_4$의 함량이 많았고, 열수추출에 비해 효소분해엑스분 쪽의 함량이 훨씬 많았다. ACE 저해능의 경우, 열수추출엑스분이 10.1%, 자가소화엑스분은 80.2%, 1차효소분해엑스분은 87.5%, 2차 효소분해엑스분은 92.1%로, 효소분해엑스분들이 월등히 높은 ACE 저해능을 나타내었다.

• 한국식품영양학회지
• /
• 제31권6호
• /
• pp.926-932
• /
• 2018

This research was conducted to investigate the changes in quality characteristics of cheonggukjang fermented with the addition of hazelnut (10, 20, 30 and 40%) including; water content, pH, hydrophilic and lipophilic substances, color, viscosity and angiotensin converting enzyme inhibition activity. There was no significant change in pH with the addition of hazelnut. The water content significantly decreased with the addition of hazelnut. Hazelnut was also found to brighten the color of cheonggukjang. L-value and b-value increased with the addition of cheonggjuang. There was an insignificant change in the a-value. There was a slight decrease in the content of hydrophilic with addition of hazelnuts. Where there was more than 20% addition of hazelnut to soybean, the viscous substance content in cheonggukjang decreased significantly. Angiotensin converting enzyme inhibitory activity increased proportionally to the amount of hazelnut added. It was identified that the addition of 40% of hazelnut made its angiotensin converting enzyme inhibitory activity 10% point higher than that of control. These results suggests that the addition of hazelnut makes it possible to produce cheongkukjang of excellent angiotensin converting enzyme inhibitory activity.

• 공업화학
• /
• 제19권3호
• /
• pp.277-286
• /
• 2008

본 논문은 미생물 성장 공정에서의 기질 저해에 관한 modified Haldane 모델의 이론적 유도를 다룬다. 생물학적 개념인 기질-수용체 복합체의 작동 메커니즘을 바탕으로 새로운 미생물학적 동특성인 N-중첩된 다중 기질 저해 모델의 유도와 더불어 일반화가 이론적으로 고찰되었는데, 이것은 효소 반응에서의 단순 기질 저해 메커니즘이 자연스럽게 확장된 것이다. 결과적으로, 본 기질 저해에 관한 modified Haldane 모델은 완전저해 기질농도라는 생물학적 상수를 포함하고 있는, 잘 설계된 4-파라메터 동특성 모델임이 밝혀졌다.

• BMB Reports
• /
• 제45권12호
• /
• pp.707-712
• /
• 2012

Human glutamate dehydrogenase isozymes (hGDH1 and hGDH2) have been known to be inhibited by palmitoyl-CoA with a high affinity. In this study, we have performed the cassette mutagenesis at six different Cys residues (Cys59, Cys93, Cys119, Cys201, Cys274, and Cys323) to identify palmitoyl-CoA binding sites within hGDH2. Four cysteine residues at positions of C59, C93, C201, or C274 may be involved, at least in part, in the inhibition of hGDH2 by palmitoyl-CoA. There was a biphasic relationship, depending on the levels of palmitoyl-CoA, between the binding of palmitoyl-CoA and the loss of enzyme activity during the inactivation process. The inhibition of hGDH2 by palmitoyl-CoA was not affected by the allosteric inhibitor GTP. Multiple mutagenesis studies on the hGDH2 are in progress to identify the amino acid residues fully responsible for the inhibition by palmitoyl-CoA.

• Biomolecules & Therapeutics
• /
• 제16권4호
• /
• pp.336-342
• /
• 2008

The resveratrol analogue piceatannol (3,5,3',4'-tetrahydroxy-trans-stilbene) is a polyphenol present in grapes and wine and reported to have anti-carcinogenic activities. To investigate the mechanism of anticarcinogenic activities of piceatannol, the effects on CYP 1 enzymes were determined in Escherichia coli membranes coexpressing recombinant human CYP1A1, CYP1A2 or CYP1B1 with human NADPH-P450 reductase. Piceatannol showed a strong inhibition of CYP1A1 and CYP1B1 in a concentration-dependent manner, and $IC_{50}$ of human CYP1A1 and CYP1B1 was 5.8 ${\mu}M$ and 16.6 ${\mu}M$, respectively. However, piceatannol did not inhibit CYP1A2 activity in the concentration of up to 100 ${\mu}M$. Piceatannol exhibited 3-fold selectivity for CYP1B1 over CYP1A1. The mode of inhibition of piceatannol was non-competitive for CYP1A1 and CYP1B1. The result that piceatannol did not inhibit CYP1B1-mediated $\alpha$-naphthoflavone ($\alpha$-NF) metabolism suggests piceatannol may act as a non-competitive inhibitor as well. In human prostate carcinoma PC-3 cells, piceatannol induces apoptosis and prevents Aktmediated signal pathway. Taken together, abilities of piceatannol to induce apoptotic cell death as well as CYP1 enzyme inhibition make this compound a useful tool for cancer chemoprevention.

• 한국식품저장유통학회지
• /
• 제11권1호
• /
• pp.94-99
• /
• 2004

솔잎의 기능성에 관한 연구를 위하여 솔잎발효추출물(PEE)과 에탄올추출물(PE 80, PE 50)로 효소적 저해활성과 아질산염 소거작용에 대하여 연구하였다. Tyrosinase의 저해효과는 솔잎발효 추출물인 PEE가 솔잎 에탄을 추출물 PE 80과 PE 50에 비해 약 5∼38％정도 저해 활성 효과가 높게 나타났다. XOase 저해효과는 PFE가 62.77％, PE 80이 64.90％, PE 50이 55.91％의 저해율을 나타내었으며, ACE 저해효과는 PFE가 78.02％, PE 80이 69.82％, PE 50이 21.75％의 순으로 솔잎발효 추출물인 PFE가 가장 높은 저해효과를 나타내었다. 아질산염 소거작용은 솔잎추출물 모두 pH 3.0이하에서 높은 분해능을 나타내었다. 유기산 함량 분석 결과, PFE, PE 80, PE 50의 세 시료 모두 항산화작용에 관여하는 ascorbic acid가 가장 많이 함유되어 있었으며, 시료별 ascorbic acid의 함량은 솔잎 발효추출물인 PFE가 가장 많이 함유되어 있는 것으로 나타났다.

• Applied Biological Chemistry
• /
• 제40권4호
• /
• pp.277-282
• /
• 1997

아라비돕시스 탈리아나의 아세토락테이트 합성 효소 (ALS)를 그 유전자를 포함하고 있는 대장균 MF 2000/pTATX로부터 부분 정제하였다. 부분 정제된 이 효소를 가지고 여러 가지 변형 화학물질들 즉, 요오드아세트산, 요오드아세타마이드, N-에틸말레이미드 (NEM), 5,5'-디티오비스(2-니트로벤조산) (DTNB), 파라염화수은벤조산 (PCMB), 그리고 페닐글리옥살 등에 대한 민감성을 조사하였다. PCMB가 가장 민감하게 저해를 했으며, DTNB와 NEM이 그 뒤를 따랐다. 이 효소의 기질인 피루브산이 요오드아세트산에 의한 활성 저해를 보호하지 못하였으므로 기질의 결합에 시스테인의 관련이 없는 것 같이 보인다. 한편, 기질이 페닐글리옥살에 의한 효소의 활성 저해를 부분적으로 보호하는 것으로 보아 기질이 아르기닌기와 상호 작용함을 암시하고 있다. 부분 정제된 효소는 발린과 이소루신에 민감하게 방해를 받았으나 루신은 그렇지 않았다. 그러나, PCMB로 변형시킨 효소는 되먹임 방해를 더 강하게 받았다. 그 외 ALS에 대한 새로운 제초제 후보인 피리미디설퍼 벤조산 유도체의 저해 효과를 검토하였다.

• 대한한의학회지
• /
• 제29권4호
• /
• pp.104-113
• /
• 2008

Objectives: The aim of this study was to investigate the influence of five herbal medicines on cytochrome P450 (CYP) 3A4 drug-metabolizing enzymes in human liver microsomes. Methods: By using of human liver microsomes, we extracted Cnidium officinale Makino, Rhus verniciflua Stokes, Prunus persica Batsch, Corydalis remota Fisch, Carthamus tinctorius Linne, which are called Hwalhyulgeoouhyak(活血祛瘀藥). Then they were incubated and measured for relative enzyme activity under incubation conditions compared to ketoconazole, which is known as a representative inhibitor of CYP 3A4. Results: We showed that all of five traditional herbal medicines had no inhibition effect of CYP 3A4 at 10, 20, 30, 40, and 50${\mu}g/m{\ell}$ doses in human liver microsomes, although Rhus verniciflua Stokes (RVS) showed a little inhibition as about 95% enzyme activity of control. However, this result was not enough to prove that RVS has a CYP 3A4 inhibition effect. Moreover, we can't confirm that those rates have significant induction effect on CYP 3A4. Conclusions: The result of this study could support that those herbal medicines are more reliable than chemical drugs, even if this is a basic step to prove that result.

• 대한화학회지
• /
• 제24권4호
• /
• pp.315-321
• /
• 1980

G. melanogenus로부터 분리한 폴리올 탈수소 효소는 이미 알려진 바의 다른 폴리올 탈수소 효소와는 달리 조효소로서 2,6-dichlorophenolindophenol (DPIP)와 같은 인위적 전자 수용체를 필수로 요구하고 있음으로 이 특수 효소의 반응메카니즘을 반응속도론적 연구를 통하여 규명코저 시도하였으며, 폴리올 산화반응에 대한 초기속도 측정실험과 효소반응 산물인 케토산에 의한 저해 실험을 통하여 이 반응은 Ping-Pong Bi-Bi형의 반응메카니즘으로 진행됨을 확인하였다. 따라서 두 기질 즉 포리올로서 D-mannitol 및 전자수용체로 DPIP가 효소에 의하여 반응이 진행될 경우 D-mannitol이 우선 효소와 작용하며 첫 반응산물로서 해당하는 케토산인 D-fructose가 생성될 것으로 기대되며 이 반응이 전체 반응속도를 조절하는 과정일 것이라고 추측하였다.

• Archives of Pharmacal Research
• /
• 제27권2호
• /
• pp.199-205
• /
• 2004

Cytochrome P450 (P450) 1 enzymes such as P450 1A1, 1A2, and 181 are known to be involved in the oxidative metabolism of various procarcinogens and are regarded as important target enzymes for cancer chemoprevention. Previously, several hydroxystilbene compounds were reported to inhibit P450 1 enzymes and were rated as candidate chemopreventive agents. In this study, we investigated the inhibitory effect of 2-[2-(3,5-dimethoxyphenyl)vinyl]-thiophene (DMPVT), produced from the chemical modification of oxyresveratrol, on the activities of P450 1 enzymes. The inhibitory potential by DMPVT on the P450 1 enzyme activity was evaluated with the Escherichia coli membranes of the recombinant human cytochrome P450 1A1, 1A2, or 1B1 coexpressed with human NADPH-P450 reductase. DMPVT significantly inhibited ethoxyresorufin O-deethylation (EROD) activities with $IC_{50}$ values of 61, 11, and 2 nM for 1A1, 1A2, and 1B1, respectively. The EROO activity in OMBA-treated rat lung microsomes was also significantly inhibited by OMPVT in a dose-dependent manner. The modes of inhibition by DMPVT were non-competitive for all three P450 enzymes. The inhibition of P450 1B1-mediated EROD activity by OMPVT did not show the irreversible mechanism-based effect. The loss of EROD activity in P450 1B1 with OMPVT incubation was not blocked by treatment with the trapping agents such as glutathione, N-acetylcysteine, or dithiothreitol. Taken together, the results suggested DMPVT to be a strong noncompetitive inhibitor of human P450 1 enzymes that should be considered as a good candidate for a cancer chemopreventive agent in humans.